CA2100777C - Composition pharmaceutique contenant du granisetron et de la dexamethasone - Google Patents

Composition pharmaceutique contenant du granisetron et de la dexamethasone Download PDF

Info

Publication number
CA2100777C
CA2100777C CA002100777A CA2100777A CA2100777C CA 2100777 C CA2100777 C CA 2100777C CA 002100777 A CA002100777 A CA 002100777A CA 2100777 A CA2100777 A CA 2100777A CA 2100777 C CA2100777 C CA 2100777C
Authority
CA
Canada
Prior art keywords
granisetron
dexamethasone
vomiting
nausea
cytotoxic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002100777A
Other languages
English (en)
Other versions
CA2100777A1 (fr
Inventor
Gareth John Sanger
Christopher Stuart Dott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2100777A1 publication Critical patent/CA2100777A1/fr
Application granted granted Critical
Publication of CA2100777C publication Critical patent/CA2100777C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002100777A 1991-01-19 1992-01-16 Composition pharmaceutique contenant du granisetron et de la dexamethasone Expired - Lifetime CA2100777C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9101221.1 1991-01-19
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals
PCT/GB1992/000091 WO1992012716A1 (fr) 1991-01-19 1992-01-16 Composition pharmaceutique contenant du granisetrone et du dexamethasone

Publications (2)

Publication Number Publication Date
CA2100777A1 CA2100777A1 (fr) 1992-07-20
CA2100777C true CA2100777C (fr) 2003-08-19

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002100777A Expired - Lifetime CA2100777C (fr) 1991-01-19 1992-01-16 Composition pharmaceutique contenant du granisetron et de la dexamethasone

Country Status (12)

Country Link
EP (1) EP0567498A1 (fr)
JP (1) JP3521143B2 (fr)
KR (1) KR930702991A (fr)
AU (1) AU658169B2 (fr)
CA (1) CA2100777C (fr)
GB (1) GB9101221D0 (fr)
IE (1) IE920148A1 (fr)
MX (1) MX9200214A (fr)
NZ (1) NZ241337A (fr)
PT (1) PT100033B (fr)
WO (1) WO1992012716A1 (fr)
ZA (1) ZA92343B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
WO2008103852A1 (fr) * 2007-02-21 2008-08-28 Victory Pharma, Inc. Distribution transdermique de dexaméthasone et de prométhazine
JP5537104B2 (ja) * 2009-09-16 2014-07-02 テルモ株式会社 制吐剤
KR101368587B1 (ko) 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
CN103222977A (zh) * 2013-05-22 2013-07-31 南京工业大学 一种格拉司琼和地塞米松复方经皮控释贴剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498466B1 (fr) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Dérivés d'indazole-3-carboxamide et de l'amide-3-carboxylique
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
AU658169B2 (en) 1995-04-06
NZ241337A (en) 1994-07-26
KR930702991A (ko) 1993-11-29
MX9200214A (es) 1992-08-01
JP3521143B2 (ja) 2004-04-19
JPH06507152A (ja) 1994-08-11
PT100033B (pt) 1999-09-30
PT100033A (pt) 1993-02-26
CA2100777A1 (fr) 1992-07-20
AU1164192A (en) 1992-08-27
GB9101221D0 (en) 1991-02-27
ZA92343B (en) 1992-12-30
IE920148A1 (en) 1992-07-29
EP0567498A1 (fr) 1993-11-03
WO1992012716A1 (fr) 1992-08-06

Similar Documents

Publication Publication Date Title
CA2328730C (fr) Traitement de l'hypertension iatrogene et liee au vieillissement et compositions pharmaceutiques utiles a cet effet
EP0533280B2 (fr) Nouvelle indication médicale pour les antagonistes des tachykinines
EP0226266B1 (fr) Utilisation d'un dérivé du tétrahydrocarbazolone pour la fabrication de médicaments
JP4925074B2 (ja) ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
EP0230370A2 (fr) Utilisation des antagonistes specifiques du récepteur pour N-méthyl-D-aspartate dans la prévention et le traitement de la neurodégénération
US4804669A (en) Treatment of pain with a piperidine
JP2004508311A (ja) 頭痛、片頭痛、悪心及び嘔吐用の医薬組成物
US5929059A (en) Pharmaceutical compositions containing granisetron and dexamethasone
US5578632A (en) Medicaments for the treatment of gastrointestinal dysfunction
KR20010015918A (ko) 안면홍조를 감소시키기 위한 플루옥세틴 히드로클로라이드
JPH0157093B2 (fr)
CA2100777C (fr) Composition pharmaceutique contenant du granisetron et de la dexamethasone
JP2000513331A (ja) 鬱病の治療におけるパロキセチン
EP0190851B1 (fr) Composition anti-inflammatoire
AU626010B2 (en) Medicaments
US5240954A (en) Medicaments
US6372763B1 (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (SSRI)
EP0059031B1 (fr) Composition analgésique et anti-inflammatoire
CA1172566A (fr) Methode de preparation de composes pharmaceutiques
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
EP0178122A2 (fr) Compositions anti-inflammatoires contenant du piroxicame
US5153216A (en) Method for treating chest pain
US3773937A (en) Method of treatment
MXPA00000522A (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry